RA
MRTX

Royce & Associates’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Royce & Associates’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20,000
Closed -$1.47M – 1202
2019
Q1 		$1.47M Sell
20,000
-11,100
-36% -$755K 0.01% 809
2018
Q4 		$1.32M Hold
31,100
– – 0.01% 813
2018
Q3 		$1.47M Sell
31,100
-20,000
-39% -$1.11M 0.01% 872
2018
Q2 		$2.52M Sell
51,100
-10,000
-16% -$378K 0.02% 776
2018
Q1 		$1.88M Sell
61,100
-60,000
-50% -$1.67M 0.01% 866
2017
Q4 		$2.21M Sell
121,100
-130,000
-52% -$2.02M 0.01% 823
2017
Q3 		$2.94M Hold
251,100
– – 0.02% 731
2017
Q2 		$917K Buy
251,100
+118,063
+89% +$452K 0.01% 985
2017
Q1 		$692K Buy
+133,037
New +$729K ﹤0.01% 1020

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return